II型子宫内膜癌死亡结局的种族与民族差异:社会人口学、临床病理及治疗因素的贡献
基于监测、流行病学和最终结果数据库2007至2016年14710例≥18岁II型子宫内膜癌女性,分析非西班牙裔白人、非西班牙裔黑人、西班牙裔及非西班牙裔亚裔/太平洋岛民之间癌症特异性和全因死亡率的差异。非西班牙裔黑人癌症特异性死亡风险高于非西班牙裔白人(HR 1.22,95%CI 1.12-1.33),临床病理、社会人口学和治疗因素分别解释了43.5%、8.1%和7.3%的差异。
要点
- 非西班牙裔黑人较非西班牙裔白人癌症特异性死亡风险升高(HR 1.22,95%CI 1.12-1.33)。
- 非西班牙裔亚裔/太平洋岛民癌症特异性死亡风险低于非西班牙裔白人(HR 0.88,95%CI 0.78-0.99)。
- 临床病理因素解释了非西班牙裔黑人与非西班牙裔白人癌症特异性死亡率差异的43.5%。
核心结论
- 非西班牙裔黑人II型子宫内膜癌患者癌症特异性死亡风险高于非西班牙裔白人,临床病理、社会人口学和治疗因素部分解释了这一差异。
- 需要多学科和多层面方法整合并处理社会与生物学因素,以减少非西班牙裔黑人女性II型子宫内膜癌死亡的不成比例负担。
研究设计与样本
- 基于监测、流行病学和最终结果数据库,纳入2007至2016年14710例≥18岁II型子宫内膜癌女性。
- 比较非西班牙裔白人、非西班牙裔黑人、西班牙裔和非西班牙裔亚裔/太平洋岛民之间的癌症特异性死亡率和全因死亡率,并采用中介分析识别差异背后的因素。
主要发现
- 非西班牙裔黑人较非西班牙裔白人癌症特异性死亡风险升高(HR 1.22,95%CI 1.12-1.33)。
- 非西班牙裔亚裔/太平洋岛民较非西班牙裔白人癌症特异性死亡风险降低(HR 0.88,95%CI 0.78-0.99)。
- 西班牙裔较非西班牙裔白人癌症特异性死亡风险降低(HR 0.91,95%CI 0.81-1.01)。
- 临床病理因素(分期、分级、组织学亚型)解释了非西班牙裔黑人与非西班牙裔白人癌症特异性死亡率差异的43.5%,社会人口学因素(保险类型、地理区域和位置、社区社会经济地位)解释了8.1%,治疗因素(治疗类型、淋巴结清扫)解释了7.3%。
- 全因死亡率结果与癌症特异性死亡率相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The burden of type II endometrial cancer (EC) is rising dramatically in the U.S. Although type II EC disproportionately affects Black women, the magnitude of racial/ethnic differences in type II EC mortality outcomes and factors underlying these differences remain understudied. We examined racial/ethnic differences in cancer-specific and overall mortality in women with type II EC and quantified the extent to which mortality differences are mediated by sociodemographic, clinicopathologic, and treatment factors. METHODS: 14,710 women ≥18 years with type II EC from 2007 to 2016 were identified from the Surveillance, Epidemiology, and End Results database. The association between race/ethnicity (non-Hispanic White [NHW], non-Hispanic Black [NHB], Hispanic, and non-Hispanic Asian/Pacific Islander [NHAPI]) and cancer-specific and overall mortality was examined. Mediation analysis was used to identify factors underlying differences in mortality outcomes. RESULTS: NHB women had a higher risk of cancer-specific mortality than NHW women (hazard ratio [HR]: 1.22, 95% CI: 1.12-1.33), whereas NHAPI (HR: 0.88, 95% CI: 0.78-0.99) and Hispanic women (HR: 0.91, 95% CI: 0.81-1.01) had a lower risk of cancer-specific mortality than NHW women. Differences in clinicopathologic (stage, grade, histologic subtype), sociodemographic (insurance type, geographic region and location, neighborhood socioeconomic status), and treatment factors (treatment type, lymphadenectomy) explained 43.5%, 8.1%, and 7.3% of the difference in cancer-specific mortality between NHB and NHW women, respectively. Similar results were noted for overall mortality. CONCLUSIONS: Multidisciplinary and multilevel approaches that integrate and address social and biological factors are needed to reduce the disproportionate burden of type II EC mortality in NHB women.
引用
- Karia PS, Huang Y, Tehranifar P, et al. Racial and ethnic differences in type II endometrial cancer mortality outcomes: The contribution of sociodemographic, clinicopathologic, and treatment factors. Gynecol Oncol. 2022. PMID: 36434946. doi:10.1016/j.ygyno.2022.11.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。